[MEDIA RELEASE] WHO discontinues hydroxychloroquine and lopinavir/ritonavir treatment arms for COVID-19

These interim trial results show that hydroxychloroquine and lopinavir/ritonavir produce little or no reduction in the mortality of hospitalized COVID-19 patients when compared to standard of care. Solidarity trial investigators will interrupt the trials with immediate effect.